Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-<it>ras </it>gene mutation

Reduction of serum IGF-I levels in patients affected with Monoclonal Gammopathies of undetermined significance or Multiple Myeloma. Comparison with bFGF, VEGF and K-<it>ras </it>gene mutation

<p>Abstract</p> <p>Background</p> <p>Serum levels of IGF-I in patients affected with multiple myeloma (MM) have been scarcely studied. The present study is aimed to explore this point comparing 55 healthy subjects, 71 monoclonal gammopaties of uncertain significance (MG...

Full description

Bibliographic Details
Main Authors: Pisani Francesco, Sperduti Isabella, Giannarelli Diana, Vona Rosa, Vercillo Giuseppe, Vitelli Gaetano, Greco Claudia, Capoluongo Ettore, Petti Maria, Ameglio Franco
Format: Article
Language:English
Published: BMC 2009-03-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/28/1/35

Similar Items

Similar Items